[10] This increases sympathetic nervous system activity, reducing hunger and potentially increasing energy expenditure
Source: AAN For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study released March 1, 2026, that will be presented at the American Academy of Neurologys 78 th Annual Meeting taking place April 18-22, 2026, in Chicago and online
doi:10.3389/fneur.2022.844697 Edison P, et al
But they target the mechanisms driving progression in ways oral DMARDs and biologics structurally can't
Cost barriers She praised Medicares new GLP-1 Bridge Program, which lowers monthly costs for eligible beneficiaries to about $50 if their Part D plans do not already provide coverage
Highlighting that the oral pill can help improve blood glucose control alongside diet and exercise, while also reducing major cardiovascular events in adults with type 2 diabetes at increased risk, the pharmaceutical company adds that the pill will be available through 70,000+ U.S